ストックスクリーナーアプリを入手
104.93
1.69%
1.74
前日終値:
$103.19
開ける：
$105
24時間の取引高:
7.36M
Relative Volume:
0.90
時価総額：
$150.72B
収益：
$17.55B
当期純損益:
$2.03B
株価収益率:
76.59
EPS:
1.37
ネットキャッシュフロー:
$2.37B
1週間 パフォーマンス:
+2.97%
1か月 パフォーマンス:
+4.88%
6か月 パフォーマンス:
+25.48%
1年 パフォーマンス:
+45.68%
1日の値動き範囲:
$104.28
$105.54
1週間の範囲:
$101.46
$105.54
52週間の値動き範囲:
$71.82
$107.17
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
104.93 | 150.72B | 17.55B | 2.03B | 2.37B | 1.37 |
|
ABT
Abbott Laboratories
|
132.82 | 223.47B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
378.22 | 139.34B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
84.85 | 107.15B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.65 | 44.54B | 5.54B | 4.18B | 259.90M | 7.00 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-16 | アップグレード | Needham | Hold → Buy |
| 2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-10-18 | ダウングレード | Needham | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-20 | 再開されました | Citigroup | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-06 | 開始されました | Wolfe Research | Outperform |
| 2022-05-27 | アップグレード | Needham | Hold → Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-05-26 | ダウングレード | Needham | Buy → Hold |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Buy |
| 2019-12-30 | 繰り返されました | Cowen | Outperform |
| 2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-09-05 | 再開されました | JP Morgan | Overweight |
| 2019-09-03 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
| 2018-09-07 | 繰り返されました | Needham | Strong Buy |
| 2018-09-04 | アップグレード | Jefferies | Hold → Buy |
| 2018-07-06 | 繰り返されました | Needham | Strong Buy |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Boston Scientific, FDA Sued Over 'Unsafe' Spinal Implant - Law360
A Changing of the Guard at Boston Scientific, Wright Medical Group and Vision-Sciences - Medical Product Outsourcing
Beyond the Balance Sheet: What SWOT Reveals About Boston Scienti - GuruFocus
$100 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today - Benzinga
June 13th Options Now Available For Boston Scientific (BSX) - Nasdaq
BOSTON SCIENTIFIC CORP SEC 10-Q Report - TradingView
Here are the highest-paid Mass. life sciences CEOs - The Business Journals
Zacks Investment Ideas Feature Highlights: Boston Scientific, Meta Platforms And Microsoft - Barchart.com
Boston Scientific Announces Results for Second Quarter 2024 - Quantisnow
Indexes Take A Well-Deserved Pause; SAP, Boston Scientific, Credicorp In Focus - Investor's Business Daily
EMEA Growth & Product Launches to Support Boston Scientific Stock - MSN
The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific And Medtronic - Barchart.com
The Zacks Analyst Blog Highlights Walmart, Toyota Motor, Boston Scientific and Autoscope - Yahoo Finance
Boston Scientific has positive ICD, Watchman FLX, AI data - MassDevice
Top Stock Reports for Walmart, Toyota Motor & Boston Scientific - MSN
Here is Why Growth Investors Should Buy Boston Scientific (BSX) Now - Yahoo Finance
Boston Scientific CFO Dan Brennan to retire after nearly 30 years with the company - MedTech Dive
Boston Scientific reports outcomes from Farapulse and Farapoint trial - Yahoo Finance
Boston Scientific (BSX) Price Target Raised by Barclays Followin - GuruFocus
Boston Sci expects $200M tariff hit, still raises guidance - BioWorld MedTech
Boston Scientific has positive Farapulse, Farapoint data - MassDevice
Boston Scientific (BSX) Reports Positive Results for FARAPULSE S - GuruFocus
Boston Scientific (BSX) Reports Positive Results for FARAPULSE System in Atrial Fibrillation Study | BSX Stock News - GuruFocus
Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints – Company AnnouncementFT.com - Financial Times
Boston Scientific (NYSE:BSX) Announces CFO Retirement And Strong Earnings Growth - Yahoo Finance
Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results - Benzinga
Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight - GlobeNewswire Inc.
Boston Scientific (BSX) Price Target Raised to $117 by Truist An - GuruFocus
RBC Capital lifts Boston Scientific stock target to $120 - Investing.com
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Nasdaq
Boston Scientific (BSX) Price Target Raised by Baird Amid Strong Q1 Performance | BSX Stock News - GuruFocus
Boston Scientific (BSX) Target Price Boosted by RBC Capital Afte - GuruFocus
Canaccord maintains Buy rating on Boston Scientific stock - Investing.com
Raymond James Adjusts Boston Scientific (BSX) Price Target, Reaffirms Strong Buy | BSX Stock News - GuruFocus
Boston Scientific Corporation (NYSE:BSX) Q1 2025 Earnings Call Transcript - Insider Monkey
Canaccord maintains Buy rating on Boston Scientific stock By Investing.com - Investing.com UK
Boston Scientific Stock (BSX): Solid Q1 Earnings Growth - Value The Markets
Petri Dish: Boston Scientific CFO retires; Biotech undergoes 1-for-20 reverse stock split - The Business Journals
Boston Scientific Corp (BSX) Q1 2025 Earnings Call Highlights: Strong Growth and Upgraded ... - Yahoo Finance
Boston Scientific Reports Strong Q1 2025 Growth - TipRanks
Boston Scientific: Q1 Earnings Snapshot - CT Insider
Boston Scientific Reports Strong Earnings Amid Challenges - TipRanks
Data backs Boston Scientific drug-eluting stent - MassDevice
BTIG Raises Price Target for Boston Scientific (BSX) to $124 Ami - GuruFocus
BTIG Raises Price Target for Boston Scientific (BSX) to $124 Amid Strong Outlook | BSX Stock News - GuruFocus
Why Boston Scientific (BSX) Stock Is Up Today - Yahoo Finance
Hedge Fund and Insider Trading News: Bill Ackman, Robert Charles Gibbins, Dan Loeb, Elliot Management, Lindblad Expeditions Holdings Inc (LIND), Boston Scientific Corp (BSX), and More - Insider Monkey
Boston Scientific Corp (BSX) Shares Up 4.85% on Apr 23 - GuruFocus
Boston Scientific says sales could grow up to 17% this year - MassDevice
Boston Scientific (BSX) Surpasses Q1 Expectations, Raises 2025 O - GuruFocus
Boston Scientific Revises 2025 Financial Goals Following Strong Q1 Results - Finimize
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
1.13%
大文字化:
|
ボリューム (24 時間):